Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development.
about
Enterovirus and parechovirus infection in children: a brief overviewMultiple capsid-stabilizing interactions revealed in a high-resolution structure of an emerging picornavirus causing neonatal sepsis.Genome and infection characteristics of human parechovirus type 1: the interplay between viral infection and type I interferon antiviral systemHuman Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3Two cases of sepsis-like illness in infants caused by human parechovirus traced back to elder siblings with mild gastroenteritis and respiratory symptomsGrowth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR.Distinctive clinical features of HPeV-3 infection in 2 neonates with a sepsis-like illnessVIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014.An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3.Human Parechovirus 3 Meningitis and Fatal Leukoencephalopathy.Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014.Strain-dependent neutralization reveals antigenic variation of human parechovirus 3.Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.Epidemiology and Immune Pathogenesis of Viral Sepsis
P2860
Q26751373-00A7EFF1-F742-4465-BA02-3B2FB1C9BE64Q27319181-86B6C127-538F-4DA8-B198-3B67FA1C3F88Q35234300-0F68A377-AC97-47FF-88CF-89C4A1DC9E44Q35861163-154CA8FE-EF96-4F39-9733-3E0A5F48A129Q36212047-830204E6-E191-4BA8-B9B8-1D83346CB315Q36558905-93EAB08E-9306-4CAB-A4A7-E021041D2B0BQ36908541-604D48A1-4361-403C-84E4-3E38C65F55AEQ37223220-146F29E2-3CE0-4B55-994A-8B57E0E3F86AQ37348675-A0737C4B-CE3C-4F7D-8834-0A0791B46C99Q37698806-2D4F966B-141B-40C7-A3C8-BC17075FED76Q38413976-80523BF0-478A-4BD0-AFAC-31A8E4DDE5D1Q40420715-08C92298-08BF-46D3-A310-0DDE156DA22CQ41932454-8EA39600-732A-4560-BF85-03B0DE695051Q47579140-12CF82AE-915D-4DDE-9EBB-D21D2B6CADC1Q57490857-2D6D53BA-08E6-4411-A325-A363D1F19FEE
P2860
Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Specific cell tropism and neut ...... nesis and therapy development.
@en
Specific cell tropism and neut ...... nesis and therapy development.
@nl
type
label
Specific cell tropism and neut ...... nesis and therapy development.
@en
Specific cell tropism and neut ...... nesis and therapy development.
@nl
prefLabel
Specific cell tropism and neut ...... nesis and therapy development.
@en
Specific cell tropism and neut ...... nesis and therapy development.
@nl
P2093
P356
P1476
Specific cell tropism and neut ...... nesis and therapy development.
@en
P2093
Brenda M Westerhuis
Dasja Pajkrt
Gerrit Koen
Joanne G Wildenbeest
Katja C Wolthers
Kimberley S M Benschop
Menno D de Jong
P304
P356
10.1099/VIR.0.043323-0
P407
P577
2012-07-25T00:00:00Z